The report states Dalmia Bharat posted a net loss of Rs 205 crore in Q2 FY27 versus a profit a year ago, with EBITDA falling 29.2% and margin contracting.
Read this note →Dalmia Bharat Limited
NSE DALBHARAT BSE 542216 INE00R701025
0 filings · 0 analysed
1,466.30
-16.78%
over 6 months
-
The report states Dalmia Bharat posted a net loss of Rs 205 crore in Q2 FY27 versus a profit a year ago, with EBITDA falling 29.2% and margin contracting.
-
HSIE Results Daily 27 Oct 26 HSIE
The report says Dalmia reported sub-par volume and margin in Q2FY27 due to weak demand and elevated costs, lowering the TP to INR 2,030.
-
Cement Q2FY27 Results Preview HSIE
The note retains BUY on Dalmia Bharat with an unchanged TP and estimates Q2FY27E EBITDA/MT of INR 754.
-
The note lists Dalmia Bharat among stocks showing weakness in the derivatives segment.
-
Dalmia Bharat Update Sep26 HSIE
The report maintains BUY with a revised target price of INR 2,110/share (12x Sep'28E consolidated EBITDA), while lowering FY27/28E EBITDA estimates by 4.5/4.8%, estimating Q2FY27E volume growth of ~6% YoY and unit EBITDA of ~INR 750/MT, cumulative FY27-29E capex of INR 135bn, net debt/EBITDA peaking at 2.5x in FY27E, and volume/EBITDA CAGR of 12/11% over FY26-29E, with central assets, Belgaum, Pune SGU, Kadapa IU and the Chennai bulk terminal taking consolidated capacity to 67mn MT by FY28-end plus the BJCL acquisition pending NCLT approval.
-
The note states Dalmia Bharat, alongside Star Cement, is an incumbent leader in the northeast generating ~INR 1,500-2,000/MT EBITDA and will benefit from limited competition until late FY29.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 27 Oct 2026, 06:56 | long | 1,625.80 | 2,030.00 | 1,470.30 | -38% | open by 2027-10-27 |
| HDFC Securities (HSIE Research) | 08 Oct 2026, 16:58 | long | 1,592.90 | 2,110.00 | 1,470.30 | -24% | open by 2027-10-08 |
| HDFC Securities | 28 Sep 2026, 08:58 | long | 1,651.60 | 2,110.00 | 1,470.30 | -40% | open by 2027-09-28 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report says Dalmia reported sub-par volume and margin in Q2FY27 due to weak demand and elevated costs, lowering the TP to INR 2,030.
Read this note →The note retains BUY on Dalmia Bharat with an unchanged TP and estimates Q2FY27E EBITDA/MT of INR 754.
Read this note →The note lists Dalmia Bharat among stocks showing weakness in the derivatives segment.
Read this note →The report maintains BUY with a revised target price of INR 2,110/share (12x Sep'28E consolidated EBITDA), while lowering FY27/28E EBITDA estimates by 4.5/4.8%, estimating Q2FY27E volume growth of ~6% YoY and unit EBITDA of ~INR 750/MT, cumulative FY27-29E capex of INR 135bn, net debt/EBITDA peaking at 2.5x in FY27E, and volume/EBITDA CAGR of 12/11% over FY26-29E, with central assets, Belgaum, Pune SGU, Kadapa IU and the Chennai bulk terminal taking consolidated capacity to 67mn MT by FY28-end plus the BJCL acquisition pending NCLT approval.
Read this note →The note states Dalmia Bharat, alongside Star Cement, is an incumbent leader in the northeast generating ~INR 1,500-2,000/MT EBITDA and will benefit from limited competition until late FY29.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief